Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
pulmonary hypertension | EFO_0001361 | D006976 | I27.20 |
Expiration | Code | ||
---|---|---|---|
BOSENTAN, TRACLEER, ACTELION | |||
2024-09-05 | ODE*, ODE-161 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pulmonary arterial hypertension | D000081029 | — | — | 3 | 3 | 8 | 11 | 10 | 34 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | 5 | 13 | 5 | 6 | 29 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | 1 | 4 | 2 | 2 | 3 | 10 |
Hypertension | D006973 | EFO_0000537 | I10 | 1 | 2 | — | 2 | 3 | 8 |
Idiopathic pulmonary fibrosis | D054990 | — | J84.112 | — | 1 | 3 | 2 | — | 5 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | 1 | 2 | — | 4 |
Interstitial lung diseases | D017563 | HP_0006530 | J84.89 | — | 1 | 1 | 1 | — | 2 |
Eisenmenger complex | D004541 | — | I27.83 | — | — | 1 | 1 | — | 2 |
Tourniquets | D014111 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sarcoidosis | D012507 | EFO_0000690 | D80-D89 | — | 2 | 1 | — | 1 | 3 |
Persistent fetal circulation syndrome | D010547 | EFO_1001103 | P29.3 | — | — | 1 | — | 1 | 2 |
Giant cell arteritis | D013700 | EFO_1001209 | M31.6 | — | — | 1 | — | — | 1 |
Low vision | D015354 | — | — | — | — | 1 | — | — | 1 |
Ischemic optic neuropathy | D018917 | EFO_1000809 | H47.01 | — | — | 1 | — | — | 1 |
Atrial heart septal defects | D006344 | Orphanet_1478 | Q21.1 | — | — | 1 | — | — | 1 |
Connective tissue diseases | D003240 | EFO_1001986 | M35 | — | — | 1 | — | — | 1 |
Diastolic heart failure | D054144 | EFO_1000899 | I50.30 | — | — | 1 | — | — | 1 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | — | — | 1 | — | — | 1 |
Pulmonary fibrosis | D011658 | — | J84.10 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Congenital heart defects | D006330 | HP_0001627 | Q24.9 | — | 2 | — | — | 3 | 5 |
Heart failure | D006333 | HP_0001635 | I50 | 1 | 1 | — | — | 2 | 3 |
Asthma | D001249 | EFO_0000270 | J45 | — | 2 | — | — | 1 | 3 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | 1 | — | — | — | 1 |
Port-wine stain | D019339 | — | Q82.5 | — | 1 | — | — | — | 1 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | — | — | — | 1 |
Hepatopulmonary syndrome | D020065 | EFO_1001346 | K76.81 | — | 1 | — | — | — | 1 |
Tricuspid atresia | D018785 | — | — | — | 1 | — | — | — | 1 |
Hypoplastic left heart syndrome | D018636 | — | Q23.4 | — | 1 | — | — | — | 1 |
Mitral valve stenosis | D008946 | EFO_0007372 | — | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
Drug interactions | D004347 | — | — | 1 | — | — | — | 2 | 3 |
Vasodilation | D014664 | — | — | 2 | — | — | — | — | 2 |
Vasoconstriction | D014661 | — | — | 2 | — | — | — | — | 2 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 1 | — | — | — | — | 1 |
Glaucoma | D005901 | EFO_0000516 | H40 | 1 | — | — | — | — | 1 |
Blood flow velocity | D001783 | — | — | 1 | — | — | — | — | 1 |
Altitude | D000531 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | — | — | 2 | 2 |
Hemophilia a | D006467 | EFO_0007267 | D66 | — | — | — | — | 2 | 2 |
Pain | D010146 | EFO_0003843 | R52 | — | — | — | — | 2 | 2 |
Pneumonia | D011014 | EFO_0003106 | — | — | — | — | — | 2 | 2 |
Hyperaldosteronism | D006929 | HP_0011736 | E26 | — | — | — | — | 2 | 2 |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | — | — | 2 | 2 |
Hypokalemia | D007008 | HP_0002900 | E87.6 | — | — | — | — | 2 | 2 |
Sleep initiation and maintenance disorders | D007319 | — | F51.01 | — | — | — | — | 2 | 2 |
Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | — | — | 2 | 2 |
Hereditary congenital and neonatal diseases and abnormalities | D009358 | — | — | — | — | — | — | 2 | 2 |
Drug common name | Bosentan |
INN | bosentan |
Description | Bosentan is a sulfonamide, a member of pyrimidines and a primary alcohol. It has a role as an antihypertensive agent and an endothelin receptor antagonist. |
Classification | Small molecule |
Drug class | endothelin receptor antagonists |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO |
PDB | — |
CAS-ID | 147536-97-8 |
RxCUI | 1468845 |
ChEMBL ID | CHEMBL957 |
ChEBI ID | 51450 |
PubChem CID | 104865 |
DrugBank | DB00559 |
UNII ID | XUL93R30K2 (ChemIDplus, GSRS) |